Vero Biotech Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for VERO BIOTECH, and what generic alternatives to VERO BIOTECH drugs are available?
VERO BIOTECH has one approved drug.
There are twenty-two US patents protecting VERO BIOTECH drugs.
There are forty-nine patent family members on VERO BIOTECH drugs in five countries and two supplementary protection certificates in two countries.
Summary for Vero Biotech
| International Patents: | 49 |
| US Patents: | 22 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Vero Biotech
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vero Biotech | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 8,607,785 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Vero Biotech | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 8,057,742 | See Plans and Pricing | See Plans and Pricing | ||||
| Vero Biotech | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 9,956,373 | See Plans and Pricing | See Plans and Pricing | ||||
| Vero Biotech | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 11,383,059 | See Plans and Pricing | See Plans and Pricing | ||||
| Vero Biotech | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 10,213,572 | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Vero Biotech
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Vero Biotech | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | 6,758,214 | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Vero Biotech Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2010021942 | See Plans and Pricing |
| Japan | 2014166557 | See Plans and Pricing |
| Japan | 5952341 | See Plans and Pricing |
| Japan | 2008510675 | See Plans and Pricing |
| Australia | 2008232413 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Vero Biotech Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0786264 | SPC/GB08/019 | United Kingdom | See Plans and Pricing | PRODUCT NAME: NITRIC OXIDE (NO); REGISTERED: UK EU/1/01/194/001 20010801 |
| 0560928 | 2002C/003 | Belgium | See Plans and Pricing | PRODUCT NAME: NITRIC OXIDE; REGISTRATION NO/DATE: EU/1/01/194/001 20010801 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
